FDA Inspection 1293624 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on February 26, 2026 in Pasadena, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 26, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pasadena, TX (United States)